Live Breaking News & Updates on Lpha Cognition Kurs

Stay updated with breaking news from Lpha cognition kurs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Alpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer's Disease Seite 1

22.02.2024 - Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (“Alpha Cognition” (ACI), or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to announce that it has filed a new . Seite 1 ....

United States , Michael Mcfadden , Alpha Cognition , Alpha Cognition Chart , Lpha Cognition Kurs , Lpha Cognition Aktie ,

Alpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offering

22.12.2023 - Alpha Cognition Inc. (CSE: ACOG, OTCQB: ACOGF) (“Alpha Cognition” or the “Company”) announces that it has completed a fourth closing pursuant to its previously announced private placement of units of the Company. Pursuant to the fourth closing, the . ....

Alpha Cognition Inc , Alpha Cognition , Alpha Cognition Chart , Lpha Cognition Kurs , Lpha Cognition Aktie ,

Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer's Disease Seite 1

27.09.2023 - Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to announce the submission of a New Drug . Seite 1 ....

Michael Mcfadden , New Drug Application , Alpha Cognition Chart , Lpha Cognition Kurs , Lpha Cognition Aktie ,